Literature DB >> 22490425

Stimulus-induced drop episodes in Coffin-Lowry syndrome.

Jin S Hahn1, André Hanauer.   

Abstract

The Coffin-Lowry syndrome (CLS) is a rare but well-defined X-linked semidominant syndrome characterized by psychomotor and growth retardation, and progressive skeletal changes. CLS is caused by loss of function mutations in the Rps6ka3 gene encoding the ribosomal S6 kinase 2 (RSK2) protein. A distinctive paroxysmal disorder has been described in some CLS patients, characterized by episodes of sudden falling, without apparent alteration of consciousness, usually induced by unexpected tactile or auditory stimuli. Duration of episodes is very short, usually lasting a few seconds. The appellation "Stimulus-induced drop episodes" (SIDEs) was proposed for these non-epileptic events in CLS patients. SIDEs are clinically heterogeneous; with some patients exhibiting cataplexy-like events characterized by sudden hypotonia and collapse, and others hyperekplexia-like episodes with a startle response. The pathophysiology of SIDEs is not well understood.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490425     DOI: 10.1016/j.ejmg.2012.03.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

1.  Recurrent Nonconvulsive Status Epilepticus in a Patient with Coffin-Lowry Syndrome.

Authors:  Markus Gschwind; Giovanni Foletti; Alessandra Baumer; Armand Bottani; Jan Novy
Journal:  Mol Syndromol       Date:  2015-05-19

2.  A Bizarre Gait as a Result of Overlapping Functional Disorder With Coffin-Lowry Syndrome.

Authors:  Ana Brás; Alexandra Pedruco; Sofia Maia; Isabel Fineza; Ana Morgadinho; Conceição Bento
Journal:  Mov Disord Clin Pract       Date:  2019-05-22

3.  Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin-Lowry syndrome.

Authors:  Elif Acar Arslan; Serdar Ceylaner; Güzide Turanlı
Journal:  Epilepsy Behav Case Rep       Date:  2014-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.